Efficacy and Safety of Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression

Magnetic Resonance Therapy Improves Clinical Phenotype and EEG Alpha Power in Posttraumatic Stress Disorder

Posttraumatic stress disorder (PTSD) is a disabling and prevalent psychiatric disorder with limited effective treatment options. In addition to the clinical features of the disease, pathologic changes in the electroencephalogram (EEG), including decreased alpha power, have been reported.

Noninvasive EEG-EKG guided trans-magnetic stimulation at natural resonance frequency in veterans with PTSD

Neuromodulation has been investigated as a therapeutic modality for neuropsychiatric disorders, such as PTSD. Recent human clinical studies of transcranial magnetic stimulation (TMS) suggest some improvement in clinical symptomatology and EEG phenotype in PTSD patients with a short course of treatment. We hypothesize clinical improvement in patients with PTSD coinciding with changes in EEG measures.

Synchronized transcranial magnetic stimulation for posttraumaticstress disorder and comorbid major depression

We conducted a prospective, sham-controlled, multisite pilot study of sTMS delivered to patients who were symptomatic despite ongoing pharmacotherapy for PTSD and MDD, hypothesizing sTMS would be feasible, safe and effective at reducing these symptoms.